ALDH1L1 and neoplasm: These in vitro and in vivo results suggested that the downregulation of ALDH1L1 in OSCC is conducive to the demand for rapid growth of tumor cells, and the upregulation of ALDH1L1 as a target can significantly inhibit tumor development.